These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10808807)

  • 1. The role of the critical care nurse in preventing heart failure after acute myocardial infarction.
    Moser DK; Frazier SK; Worster PL; Clarke J
    Crit Care Nurse; 1999 Oct; 19(5 Suppl):11-5. PubMed ID: 10808807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiotensin converting enzyme inhibitors on remodeling in clinical trials.
    Greenberg BH
    J Card Fail; 2002 Dec; 8(6 Suppl):S486-90. PubMed ID: 12555162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ambulatory management of patients after myocardial infarction].
    Bloch A
    Rev Med Suisse Romande; 2000 Feb; 120(2):159-66. PubMed ID: 10748703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognizing and managing asymptomatic left ventricular dysfunction after myocardial infarction.
    Albert NM; Lewis C
    Crit Care Nurse; 2008 Apr; 28(2):20-37; quiz 38. PubMed ID: 18378726
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventing congestive heart failure.
    Cohn JN
    Am Fam Physician; 1998 Apr; 57(8):1901-4. PubMed ID: 9575327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
    Ferrari R;
    Arch Intern Med; 2006 Mar; 166(6):659-66. PubMed ID: 16567606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bridging the treatment gap: the secondary care perspective.
    Dancy M
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii32-4, discussion ii43-8. PubMed ID: 15831609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure with preserved systolic function: giving well-deserved attention to the "other" heart failure.
    Albert NM
    Crit Care Nurs Q; 2007; 30(4):287-96; quiz 297-8. PubMed ID: 17873564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
    Weir R; McMurray JJ
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system.
    Guo X; Saini HK; Wang J; Gupta SK; Goyal RK; Dhalla NS
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):717-32. PubMed ID: 16076281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE inhibitors after acute myocardial infarction.
    Cheng TO
    Arch Intern Med; 1995 Mar; 155(6):645. PubMed ID: 7887763
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of L-2286, a poly(ADP-ribose)polymerase inhibitor and enalapril on myocardial remodeling and heart failure.
    Bartha E; Kiss GN; Kalman E; Kulcsár G; Kálai T; Hideg K; Habon T; Sumegi B; Toth K; Halmosi R
    J Cardiovasc Pharmacol; 2008 Sep; 52(3):253-61. PubMed ID: 18806606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
    Ferrari R; Papa K; Bernocchi P; Gimbatti OJ; Golcea SS; Bettini A; Ceconi C
    Ital Heart J; 2005 Nov; 6 Suppl 7():24S-32S. PubMed ID: 16485514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential novel pharmacological therapies for myocardial remodelling.
    Landmesser U; Wollert KC; Drexler H
    Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors and left ventricular remodeling: implications for nurses.
    Hoffmann RL; Reeder SJ
    Dimens Crit Care Nurs; 1998; 17(5):256-63. PubMed ID: 10639985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Remodeling with angiotensin-converting enzyme inhibitors: from GISSI to PREAMI].
    Nicolosi GL
    Ital Heart J; 2005 Nov; 6 Suppl 7():33S-39S. PubMed ID: 16485515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of treatment recommendations and specialist intervention on care provided by primary care physicians to patients with myocardial infarction or heart failure.
    Guadagnoli E; Normand SL; DiSalvo TG; Palmer RH; McNeil BJ
    Am J Med; 2004 Sep; 117(6):371-9. PubMed ID: 15380493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Post infarction (congestive) heart failure].
    Degawa T; Yamaguchi T
    Ryoikibetsu Shokogun Shirizu; 1996; (12):46-50. PubMed ID: 9047406
    [No Abstract]   [Full Text] [Related]  

  • 20. Left ventricular remodeling after myocardial infarction: past, present, and future.
    Tiyyagura SR; Pinney SP
    Mt Sinai J Med; 2006 Oct; 73(6):840-51. PubMed ID: 17117309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.